NCT00338026View on ClinicalTrials.gov

A Phase I Study of ECO-4601 in Patients With Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
TumorsGliomaColorectal CancerLung CancerBreast CancerOvarian CancerPancreatic CancerProstate Cancer
Interventions
DRUG

ECO-4601

Continuous IV infusion for 14 days with 7 days recovery (21 day cycle)

Trial Locations (2)

J4V 2H1

Hôpital Charles LeMoyne, Greenfield Park

H3T 1E2

Sir Mortimer B. Davis Jewish General Hospital, Montreal

Sponsors
All Listed Sponsors
lead

Thallion Pharmaceuticals

INDUSTRY

NCT00338026 - A Phase I Study of ECO-4601 in Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter